BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuchs K, Kiss A, Bize PE, Duran R, Denys A, Hopfgartner G, Borchard G, Jordan O. Mapping of drug distribution in the rabbit liver tumor model by complementary fluorescence and mass spectrometry imaging. J Control Release 2018;269:128-35. [PMID: 29101054 DOI: 10.1016/j.jconrel.2017.10.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Porta Siegel T, Hamm G, Bunch J, Cappell J, Fletcher JS, Schwamborn K. Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues. Mol Imaging Biol 2018;20:888-901. [PMID: 30167993 DOI: 10.1007/s11307-018-1267-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
2 Mikhail AS, Negussie AH, Mauda-Havakuk M, Owen JW, Pritchard WF, Lewis AL, Wood BJ. Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications. Expert Opin Drug Deliv 2021;18:383-98. [PMID: 33480306 DOI: 10.1080/17425247.2021.1835858] [Reference Citation Analysis]
3 Lamont L, Hadavi D, Viehmann B, Flinders B, Heeren RMA, Vreeken RJ, Porta Siegel T. Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison. Anal Bioanal Chem 2021;413:2779-91. [PMID: 33770207 DOI: 10.1007/s00216-021-03210-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 He Q, Sun C, Liu J, Pan Y. MALDI-MSI analysis of cancer drugs: Significance, advances, and applications. TrAC Trends in Analytical Chemistry 2021;136:116183. [DOI: 10.1016/j.trac.2021.116183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Johnson RW Jr, Talaty N. Tissue Imaging by Mass Spectrometry: A Practical Guide for the Medicinal Chemist. ACS Med Chem Lett 2019;10:161-7. [PMID: 30783497 DOI: 10.1021/acsmedchemlett.8b00480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bertzbach LD, Kaufer BB, Karger A. Applications of mass spectrometry imaging in virus research. Adv Virus Res 2021;109:31-62. [PMID: 33934829 DOI: 10.1016/bs.aivir.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 de Maar JS, Sofias AM, Porta Siegel T, Vreeken RJ, Moonen C, Bos C, Deckers R. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment. Theranostics 2020;10:1884-909. [PMID: 32042343 DOI: 10.7150/thno.38625] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
8 Rudkouskaya A, Sinsuebphon N, Ward J, Tubbesing K, Intes X, Barroso M. Quantitative imaging of receptor-ligand engagement in intact live animals. J Control Release 2018;286:451-9. [PMID: 30036545 DOI: 10.1016/j.jconrel.2018.07.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
9 Stolley DL, Crouch AC, Özkan A, Seeley EH, Whitley EM, Rylander MN, Cressman ENK. Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies. Pharmaceutics 2020;12:E1243. [PMID: 33419304 DOI: 10.3390/pharmaceutics12121243] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]